Back to today’s briefing

Story perspectives

Chemours Shares Rise on Market Strength and Legal Wins

3/29/2025

28 5

Summary

Story summary

Chemours benefits from a strong market, according to Mizuho's report.
The industry is transitioning to next-gen refrigerants, normalizing stockpiling of banned Freon.
Positive developments in PFAS litigation suggest a potential settlement ahead of the New Jersey trial.
Mizuho upgrades Chemours to "outperform," resulting in a 2.6% increase in shares to $14.19.

1 of 1

Story summary

Chemours benefits from a strong market, according to Mizuho's report.
The industry is transitioning to next-gen refrigerants, normalizing stockpiling of banned Freon.
Positive developments in PFAS litigation suggest a potential settlement ahead of the New Jersey trial.
Mizuho upgrades Chemours to "outperform," resulting in a 2.6% increase in shares to $14.19.